OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could help throat cancer patients get less radiation
Disease control Recruiting nowThis phase II trial tests whether a blood test that detects HPV DNA can help doctors decide the right amount of radiation for people with HPV-positive throat cancer. About 455 participants will either have surgery or receive standard chemotherapy plus radiation, but the radiation…
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
HPV throat cancer study tracks hidden infections in women and partners
Knowledge-focused Recruiting nowThis study is checking how often women who have HPV-positive throat cancer, or whose partner has it, also have HPV infections in their genital or anal areas. Researchers will compare these rates to similar women without cancer. The goal is to learn more about how HPV spreads and …
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC